[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR3093622B1 - Procédé et système de fabrication d’un kit à vapoter, kit à vapoter ainsi obtenu, procédé de fabrication d’un flacon de liquide de vapotage, et flacon ainsi obtenu, et programme d’ordinateur - Google Patents

Procédé et système de fabrication d’un kit à vapoter, kit à vapoter ainsi obtenu, procédé de fabrication d’un flacon de liquide de vapotage, et flacon ainsi obtenu, et programme d’ordinateur Download PDF

Info

Publication number
FR3093622B1
FR3093622B1 FR1902518A FR1902518A FR3093622B1 FR 3093622 B1 FR3093622 B1 FR 3093622B1 FR 1902518 A FR1902518 A FR 1902518A FR 1902518 A FR1902518 A FR 1902518A FR 3093622 B1 FR3093622 B1 FR 3093622B1
Authority
FR
France
Prior art keywords
vape
manufacturing
kit
vial
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1902518A
Other languages
English (en)
Other versions
FR3093622A1 (fr
Inventor
Arnaud Mehl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bar A Diy
Original Assignee
Bar A Diy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bar A Diy filed Critical Bar A Diy
Priority to FR1902518A priority Critical patent/FR3093622B1/fr
Publication of FR3093622A1 publication Critical patent/FR3093622A1/fr
Application granted granted Critical
Publication of FR3093622B1 publication Critical patent/FR3093622B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B3/003—Filling medical containers such as ampoules, vials, syringes or the like
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B2220/00—Specific aspects of the packaging operation
    • B65B2220/14—Adding more than one type of material or article to the same package

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procédé et système de fabrication d’un kit à vapoter, kit à vapoter ainsi obtenu, procédé de fabrication d’un flacon de liquide de vapotage, et flacon ainsi obtenu, et programme d’ordinateur Le procédé de fabrication d’un kit à vapoter comprend : - la réception, par un processeur d’un dosage et d’un volume total d’une composition à vapoter, - la détermination, par le processeur, d’un volume de deux compositions sources de base à distribuer, de composition source d’arôme à distribuer, et d’un volume de composition source nicotinique,lesdits volumes respectant, quand assemblés, les teneurs et le volume total,- la sélection d’un flacon (2) dont la contenance correspond audit volume total de composition à vapoter, - la distribution contrôlée des volumes de deux compositions sources de base et du volume de composition source d’arôme, - l’association au flacon d’un flacon (10) de composition source nicotinique. Figure pour l’abrégé : Fig. 2
FR1902518A 2019-03-12 2019-03-12 Procédé et système de fabrication d’un kit à vapoter, kit à vapoter ainsi obtenu, procédé de fabrication d’un flacon de liquide de vapotage, et flacon ainsi obtenu, et programme d’ordinateur Active FR3093622B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1902518A FR3093622B1 (fr) 2019-03-12 2019-03-12 Procédé et système de fabrication d’un kit à vapoter, kit à vapoter ainsi obtenu, procédé de fabrication d’un flacon de liquide de vapotage, et flacon ainsi obtenu, et programme d’ordinateur

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1902518 2019-03-12
FR1902518A FR3093622B1 (fr) 2019-03-12 2019-03-12 Procédé et système de fabrication d’un kit à vapoter, kit à vapoter ainsi obtenu, procédé de fabrication d’un flacon de liquide de vapotage, et flacon ainsi obtenu, et programme d’ordinateur

Publications (2)

Publication Number Publication Date
FR3093622A1 FR3093622A1 (fr) 2020-09-18
FR3093622B1 true FR3093622B1 (fr) 2021-04-09

Family

ID=67383995

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1902518A Active FR3093622B1 (fr) 2019-03-12 2019-03-12 Procédé et système de fabrication d’un kit à vapoter, kit à vapoter ainsi obtenu, procédé de fabrication d’un flacon de liquide de vapotage, et flacon ainsi obtenu, et programme d’ordinateur

Country Status (1)

Country Link
FR (1) FR3093622B1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201315499D0 (en) 2013-08-30 2013-10-16 British American Tobacco Co A vending machine
US11178914B2 (en) * 2014-05-23 2021-11-23 Revolutionary Electronic Design, LLC Vaping liquid dispensing and vending
US20160366929A1 (en) 2015-06-22 2016-12-22 Mark Curtis Akers Method of Customizing a Vaping Composition
US10759554B2 (en) * 2017-02-02 2020-09-01 Rai Strategic Holdings, Inc. Dispenser unit for aerosol precursor

Also Published As

Publication number Publication date
FR3093622A1 (fr) 2020-09-18

Similar Documents

Publication Publication Date Title
Strati et al. Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma
Ganetsky et al. Higher tacrolimus concentrations early after transplant reduce the risk of acute GvHD in reduced-intensity allogeneic stem cell transplantation
Macdougall et al. Current status of the measurement of blood hepcidin levels in chronic kidney disease
Pauwels et al. Therapeutic drug monitoring in neonates
MA45562B1 (fr) Préparation pharmaceutique liquide stable
Østerberg et al. Pharmacokinetics of desmopressin administrated as an oral lyophilisate dosage form in children with primary nocturnal enuresis and healthy adults
Kappeler et al. Higher bioavailability of magnesium citrate as compared to magnesium oxide shown by evaluation of urinary excretion and serum levels after single-dose administration in a randomized cross-over study
Qu et al. Morin exhibits anti-inflammatory effects on IL-1β-stimulated human osteoarthritis chondrocytes by activating the Nrf2 signaling pathway
Kormány et al. Reliability of simulated robustness testing in fast liquid chromatography, using state-of-the-art column technology, instrumentation and modelling software
Bartoli et al. Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials
Tainio et al. Pubertal development is normal in adolescents after renal transplantation in childhood
WO2005065311A3 (fr) Recherche de sites web deja visites
FR3093622B1 (fr) Procédé et système de fabrication d’un kit à vapoter, kit à vapoter ainsi obtenu, procédé de fabrication d’un flacon de liquide de vapotage, et flacon ainsi obtenu, et programme d’ordinateur
Kannaiah et al. Application of advanced environmentally benign assessment tools in determining ternary cardiovascular drug combination by RP-HPLC with analytical quality by design: application to stability indicating method evaluation
EP4331699A3 (fr) Évaporateur rotatif capable de quantifier précisément un liquide concentré et/ou un distillat
Janicki-Deverts et al. Socioeconomic status, antioxidant micronutrients, and correlates of oxidative damage: the Coronary Artery Risk Development in Young Adults (CARDIA) study
WO2017080046A1 (fr) Procédé pour mesurer la pureté optique d'un intermédiaire d'ézétimibe
Lin et al. Examining the association of circulating 25-hydroxyvitamin D with kidney cancer risk: a meta-analysis
Jin et al. The pharmacokinetics and safety of idelalisib in subjects with severe renal impairment
Razvodovsky Beverage‐specific alcohol sale and cardiovascular mortality in Russia
Hess et al. Chromatographic separation of R-(−)/S-(+)-enantiomers of amphetamine and methamphetamine: differentiation between single methamphetamine consumption and co-consumption with amphetamine using enantioselective quantitative LC-MS/MS analysis
Partridge et al. The increasing use and abuse of tapentadol and its incorporation into a validated quantitative method
Droz et al. Multivitamins/multiminerals in Switzerland: not as good as it seems
Spanoudakis et al. The JAK2V617F point mutation increases the osteoclast forming ability of monocytes in patients with chronic myeloproliferative neoplasms and makes their osteoclasts more susceptible to JAK2 inhibition
Gonçalves et al. The fall of the empire: the americanization of English

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20200918

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6